Related Experiment Video
Updated: Oct 2, 2025

05:41
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
765
Non-Marked Hypoechogenic Nodules: Multicenter Study on the Thyroid Malignancy Risk Stratification and Accuracy Based
Peteris Prieditis1,2, Maija Radzina1,2, Madara Mikijanska2
1Radiology Research Laboratory, Riga Stradins University, LV-1007 Riga, Latvia.
Medicina (Kaunas, Lithuania)
|February 25, 2022
Summary
Classifying non-marked hypoechoic thyroid nodules as TIRADS 3 improves the modified Thyroid Imaging Reporting and Data System (M-TIRADS) score accuracy. This strategy reduces overdiagnosis and unnecessary fine needle aspiration (FNA) biopsies.
Area of Science:
- Radiology
- Oncology
- Endocrinology
Background:
- Thyroid nodules are common, and accurate malignancy risk stratification is crucial.
- The Thyroid Imaging Reporting and Data System (TIRADS) aids in classifying nodules based on ultrasound features.
- Evaluating specific ultrasound criteria, like non-marked hypoechogenicity, is key to refining diagnostic accuracy.
Purpose of the Study:
- To assess the predictive value of "non-marked hypoechogenicity" for thyroid nodule malignancy.
- To determine if classifying these nodules as TIRADS 3 enhances the modified TIRADS (M-TIRADS) score's accuracy.
- To evaluate the impact on reducing unnecessary fine needle aspiration (FNA) biopsies.
Main Methods:
- A retrospective analysis of 795 thyroid nodules from 767 patients undergoing ultrasonography and ultrasound-guided fine needle aspiration biopsy.
- Nodules were classified using Kwak TIRADS and a modified TIRADS (M-TIRADS) system based on suspicious ultrasound features.
- Histopathology and specific cytology results served as the reference standard for malignancy assessment.
Main Results:
- The M-TIRADS system demonstrated high sensitivity (93.02%) and specificity (81.31%) for malignancy detection.
- Classifying non-marked hypoechoic nodules as TIRADS 3 significantly improved M-TIRADS accuracy (78.26% vs. 48.11% for Kwak TIRADS).
- This classification strategy did not significantly alter malignancy risk in TIRADS 3, potentially reducing overdiagnosis and FNA procedures.
Conclusions:
- Non-marked hypoechoic nodules exhibit a low risk of malignancy.
- Classifying these nodules as TIRADS 3 enhances M-TIRADS predictive value and overall accuracy.
- The proposed M-TIRADS modification aids in reducing overdiagnosis and unnecessary FNA biopsies for thyroid nodules.

